✨ Grateful for the opportunity to present some data from my lab today at #EACR2025 in Lisbon! 🧬🔬🇵🇹 It was a pleasure to engage with such an inspiring community of researchers.💡🙌 Thanks to everyone who stopped by, asked questions, and shared ideas — exciting things ahead! 🚀 @helloeacr.bsky.social

First time at #EACR — excited to kick off this incredible meeting in beautiful Lisbon! Let the science (and sunshine) begin ☀️🇵🇹 @EACRnews #Lisboa #EACR2025 @helloeacr.bsky.social

Feeling very grateful! 🤩🎉 A heartfelt thank you to my amazing MD students for the kind congratulations on my successful habilitation as Privatdozent (Priv.-Doz.) 🐥🎓 😁

Stellar Keynote lecture from Laura Mackay on TRM cell fate at #SID25 in San Diego @siderm.bsky.social 🤓🤩🎉

Big thanks to the Society for Investigative Dermatology for an amazing meeting in San Diego so far! Honored to receive an award for our work and the invitation to present 🥳Grateful for the inspiring science, conversations, and community! ☀️#SID2025#DermResearch  @siderm.bsky.social

Auftakt für TRYTRAC, das europäische Nachwuchsprogramm von Cancer Core Europe (CCE): Junge Wissenschaftler:innen aus sieben Top-Krebszentren – darunter vier Fellows aus Heidelberg – trafen sich am Karolinska Institutet in Stockholm. 🔗 www.nct-heidelberg.de/das-nct/news...

Recommended 📖 “Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicities” @natureportfolio.nature.com co-authored by @drrobinreschke.bsky.social from @nct-heidelberg.bsky.social @dkfz.bsky.social 🔗 www.nature.com/articles/s41...

🚨New research highlight: study on managing immunotherapy side effects without weakening anti-tumor power! ECP reduces harmful immune activity via neutrophils/T cells & promotes M2 macrophages via adiponectin. Promising results from Zeiser et al. 🔬 🧪 🧫 Full summary: www.nature.com/articles/s41...

📖 “Targeting molecular pathways to control immune checkpoint inhibitor toxicities” co-authored by @drrobinreschke.bsky.social  from @nct-heidelberg.bsky.social  @dkfz.bsky.social  🔗 https://www.cell.com/trends/immunology/fulltext/S1471-4906(24)00299-0

Heidelberg is placing first when it comes to #startup founders per capita in #Germany. With 13.5 new startups per 100.000 inhabitants in 2024, Heidelberg is outperforming startup hotspots such as #Berlin and #Munich. The full report is here: startupverband.de/fileadmin/st...

Now featured and OPEN ACCESS 💫👏🏻🚀

Targeting molecular pathways to control immune checkpoint inhibitor toxicities @drrobinreschke.bsky.social @jhu.edu @harvard.edu oncodaily.com/science/immu... #Cancer #CancerTreatment #ImmuneCheckpointBlockade #OncoDaily #Oncology #Medicine #Health

Comprehensive interdisciplinary review on current and emerging therapeutic targets to treat immune-related adverse events (irAE). A rapidly evolving field of high clinical relevance elegantly summarized by Jessica Hassel and colleagues @dkfz.bsky.social @cellpress.bsky.social doi.org/10.1016/j.it...

Review: Targeting molecular pathways to control immune checkpoint inhibitor toxicities www.cell.com/trends/immun...

Hot off the press 🔥 Very proud of this collaboration! 💫 @Harvard @JohnsHopkins @UChicago @UniHeidelberg Interested in immunotherapy-induced toxicity? 🤓 This is a must-read 🤩 #immunology #science #cancer #research @nct-heidelberg.bsky.social @dkfz.bsky.social www.cell.com/trends/immun...

⚠️ Anti-PD1 therapy could serve as an effective systemic treatment for patients with basal cell nevus syndrome who are resistant to hedgehog inhibitors, leveraging the immune system to address new occurrences of basal cell carcinoma 💡🧠🔬. 🔗 Read the full study here: jamanetwork.com/journals/jam...

🌟 Our latest article gives an update about prognostic biomarkers in evolving melanoma immunotherapy: From PD-L1 to gut microbiota and beyond 🧬💊 Enjoy the weekend read 📖 : link.springer.com/article/10.1... 📌 #Melanoma #Immunotherapy #ScienceForAll #ResearchMatters #Innovation #dermatology ---

What an amazing Secret Santa exchange on the lab floor! 🤩🎁🎄 So much laughter, surprises, and holiday cheer – can't wait to do it again next year! ✨🎅 @nct-heidelberg.bsky.social

Dermatology: A group for researchers, clinicians, patient advocates, journals, and institutions passionate about dermatology research and advancing skin health! 🩺✨ #Dermatology #SkinHealth #ScienceCommunity Leave a comment, if you want to join the starter pack 😊 go.bsky.app/7BoDoFw

Favorite protein: Dickkopf-related protein 1 Dickkopf is German for bullhead or bullethead 😂

Everything #spatialomics - A hub for researchers, clinicians, companies, journals, and institutions exploring spatial omics technologies. Leave a comment, if you’d like to join 🧬🙂 #SpatialOmics #Visium #Xenium #MERSCOPE #MultiplexIF #MIBI #OmicsResearch #Biotech #Innovation go.bsky.app/zcDshW

Skin Cancer Research: Melanoma and beyond. A space for patient advocates, scientists, physicians, institutions, and journals dedicated to advancing skin cancer research. 🧫🧑‍🔬🔬 Leave a comment and let me know if you'd like to join! #Cure #SkinCancer #Research go.bsky.app/2wqZKrA